Replies to post #197178 on Biotech Values

[DewDiligence]

MYL +9%; PRGO -7% (eom).

[DewDiligence]

MYL augments women’s-health business with acquisition of Jai Pharma for undisclosed price:

http://finance.yahoo.com/news/mylan-completes-acquisition-certain-businesses-123000416.html

[DewDiligence]

PRGO buys US rights to AZN’s Entocort (for Crohn’s disease) for $380M:

http://www.reuters.com/article/2015/11/23/astrazeneca-ma-perrigo-idUSL8N13I0OU20151123#5ryF3uvqPkJj5sJk.97

AZN had previously divested the ex-US rights to this drug.